FDA Delays Exelixis' Zanzalintinib Review: What It Means for Investors
The FDA's delay in reviewing Exelixis' zanzalintinib raises questions for investors about future revenue and growth.
Crude Oil Prices Surge Past $102: Implications for US and Canadian Energy Markets
Crude oil prices have surpassed $102, driven by geopolitical tensions and supply concerns, impacting US and Canadian energy sectors.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
Consumer Sentiment Plummets as Inflation Fears Rise, Potential Fed Rate Hike Looms
Consumer sentiment drops to 47.8, sparking inflation concerns and signaling possible Fed interest rate hikes.
Exelixis Faces Setback as FDA Extends Review of Zanzalintinib
Exelixis faces uncertainty as the FDA prolongs its review of zanzalintinib, raising questions about future revenue and s…
SPS Commerce Stock Jumps Amid Acquisition Talks with GTCR
SPS Commerce shares surged as GTCR expresses acquisition interest. Explore the implications for the tech sector.
NextEra and Dominion Merger: A New Era for U.S. Utilities
The merger between NextEra Energy and Dominion Energy could reshape the U.S. utility landscape, impacting customers and …
Merck and Moderna's mRNA Breakthrough: Implications for the Future of Cancer Treatment
The Phase 3 INTerpath-001 trial results present significant implications for Merck and Moderna's cancer treatment strate…
Quantum BioPharma's FDA Clearance: A Game Changer for MS Treatment
Quantum BioPharma's FDA clearance for Lucid-MS could reshape MS treatment and enhance investor confidence.
Technical Analysis: US Stocks at a Crossroads Amid Rising Oil Prices and Inflation Concerns
As rising oil prices and inflation loom, US stocks face critical support levels that could shape market sentiment.
Merck (MRK) and Moderna (MRNA) Achieve Breakthrough in mRNA Cancer Vaccine Development: What it Means for Investors
Merck and Moderna's Phase 3 trial results for their mRNA cancer vaccine could reshape oncology and investor sentiment.
Revolution Medicines (RVMD) Gains Momentum Post-FDA Approval: What Investors Should Know
Revolution Medicines is gaining traction following FDA approval for Rasonque, signaling potential market shifts.